Fresenius Medical Care has successfully completed its merger with NxStage Medical, Inc.

More Info

NxStage Kidney Care Brings Flexible Therapy Options To Greater Boston Area

NxStage's Wakefield and Norwood Kidney Care Centers offer patients flexible dialysis therapy options, including Home Nocturnal Hemodialysis with the NxStage System One

LAWRENCE, Mass., Feb. 25, 2015 /PRNewswire/ -- NxStage® Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), today announced the opening of two dialysis centers in the suburbs of Boston, Massachusetts. Conveniently located in Wakefield and Norwood, the centers are led by teams of highly trained medical staff committed to providing high quality, personalized care to dialysis patients and their families.

Both the Wakefield and Norwood facilities offer multiple therapy options using the NxStage System One™ including home hemodialysis (HHD), home nocturnal hemodialysis, flexible in-center hemodialysis, and short-term respite care, with schedule flexibility to meet the health and lifestyle needs of the patient. The centers also offer peritoneal dialysis (PD) therapy. All NxStage Kidney Care centers offer home dialysis training that is customized to meet the needs of the patient.

"Our focus is on putting the patient first. By listening to our patients' needs and priorities we develop personalized education, training and flexible treatment plans that provide high quality care," said Dr. Christopher Ying, Medical Director at NxStage Kidney Care in Wakefield. Dr. Ying is affiliated with Lahey Hospital & Medical Center and Tufts School of Medicine. "We help our patients choose a dialysis therapy that best meets their health and lifestyle goals, as well as their desire to do dialysis when and where they want, including while they are sleeping."

"As nephrologists we want our patients to have the best care, access to the best treatment, and have the best quality of life," said Dr. John Danziger, Medical Director at NxStage Kidney Care in Norwood. Dr. Danziger is an Attending at Beth Israel Deaconess Medical Center and an Assistant Professor at Harvard Medical School. "I am excited to offer patients dialysis options that will provide them as much convenience as possible."

Like all NxStage Kidney Care facilities, the Boston-area centers are furnished with modern, comfortable amenities, offering relaxed therapy environments.

"As a Massachusetts based company, we are thrilled to be providing local dialysis patients with access to the clinical and quality of life benefits possible with our flexible dialysis therapies," said Robert Brown, President of NxStage Kidney Care. "We invite patients and their care partners to come tour our new centers and meet our staff. We think you will be pleasantly surprised with the patient experience we can offer to help meet your needs and preferences. Seeing is believing!"

NxStage Kidney Care Massachusetts Locations:

Boston North
107 Audubon Rd, Ste. 1-60
Wakefield, MA 01880
(781) 928-9277

Boston South
500 Providence Highway
Norwood, MA 02062
(781) 619-1400

For more information about NxStage Kidney Care's home and flexible in-center options in Massachusetts please visit

About NxStage Kidney Care

NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), is innovating a dialysis care model that is intended to support and encourage patient centered care and provide enhanced access to the life-changing benefits of home therapy as well as flexible in-center options. By leveraging NxStage's home leadership and the innovative technology of its System One, NxStage Kidney Care is committed to helping patients take control of their dialysis and to allowing physicians the flexibility to prescribe what is truly best for their patients. For more information, please visit or call (866) 694-2707.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended September 30, 2014. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Media contact:
Kristen K. Sheppard, Esq.
Tel: (978) 332-5923